Federation Des Caisses Desjardins Du Quebec Corcept Therapeutics Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 30, 2024	SELL	$11.0 - $18.26 $46,112 - $76,545	-4,192 Closed	0 $0
Q1 2020 Aug 30, 2024	BUY	$10.11 - $14.04 $42,381 - $58,855	4,192 New	4,192 $50.4 Million
Q2 2019 Aug 30, 2024	SELL	$9.78 - $12.76 $234,671 - $306,176	-23,995 Closed	0 $0
Q1 2019 Aug 30, 2024	BUY	$10.03 - $15.71 $239,014 - $374,369	23,830 Added 14442.42%	23,995 $282 Million
Q4 2018 Aug 30, 2024	BUY	$11.29 - $17.19 $1,862 - $2,836	165 New	165 $2.2 Million
Q3 2018 Aug 30, 2024	SELL	$12.27 - $15.65 $47,484 - $60,565	-3,870 Reduced 95.91%	165 $2.31 Million
Q2 2018 Aug 30, 2024	SELL	$15.3 - $19.69 $400,890 - $515,917	-26,202 Reduced 86.66%	4,035 $63.4 Million
Q1 2018 Aug 30, 2024	SELL	$14.59 - $25.5 $392,835 - $686,587	-26,925 Reduced 47.1%	30,237 $498 Million
Q4 2017 Aug 30, 2024	SELL	$15.77 - $20.72 $35,245 - $46,309	-2,235 Reduced 3.76%	57,162 $1.03 Billion
Q3 2017 Aug 30, 2024	BUY	$12.3 - $19.3 $730,583 - $1.15 Million	59,397	59,397 $1.15 Billion

Others Institutions Holding CORT

# of Institutions

361

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$1.12 Billion
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$681 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.1M
Shares

$551 Million
16.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$443 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$259 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account